Emma Walmsley

The podcast features Emma Walmsley, the CEO of GSK, Daniel Kahneman, a Nobel prize-winning psychologist, and Claire Hughes-Johnson, the one-time COO of Stripe. They discuss lessons in leadership outside the office, the importance of leadership and clarity, the value of being explicit as a manager, and the significance of stepping back and effective leadership.

Andrew Palmer learns leadership lessons from CEO of GSK, Emma Walmsley; Nobel prize-winning psychologist, Daniel Kahneman; and one-time COO of Stripe, Claire Hughes-Johnson. Topics discussed include leadership experiments, defining company purpose, effective decision-making, being explicit as a manager, improving team performance, and reflections on leadership challenges.

In this engaging discussion, Emma Walmsley, CEO of GSK and a key player in pharmaceuticals, shares insights on drug discovery and the integration of AI in speeding up medical advancements. She highlights GSK's breakthroughs in cancer treatments and respiratory medicine, while tackling the challenges of drug pricing and access. Emma also emphasizes the need for culture change within companies to foster innovation and accountability, and the significance of curiosity in leadership. Tune in for a captivating look at the future of healthcare!

In this insightful discussion, PayPal's Alex Chriss delves into enabling small-business resilience through digital payments. Land O'Lakes' Beth Ford shares her mission to uplift rural America and strengthen community ties. Bob Jordan from Southwest Airlines emphasizes an employee-first culture, while Ynon Kreiz of Mattel highlights the emotional impact of brand evolution. GSK's Emma Walmsley discusses innovation in healthcare R&D, and Nordstrom's Pete Nordstrom stresses staying relevant with a customer-centric approach. The leaders also tackle the integration of AI and the challenges posed by global competition.

Colleen McHugh, an investment consultant with Wealthify, explores the UK's low investment levels and upcoming FCA guidance to broaden investment support. Geoffrey Cleveland, chief economist at Payden & Rygel, discusses the recent US Federal Reserve rate cuts and their potential effects on the UK and financial markets. Meanwhile, Emma Walmsley, former CEO of GlaxoSmithKline, shares insights on the company's strategic investments in the US and highlights innovative research in pharmaceuticals.